Spain

Reports in the Spanish press suggest that Janssen-Cilag, Eli Lilly and Merck & Co have joined fellow multinational drugmaker Pfizer in adopting a controversial new distribution... 2006-11-23

Spain has approved a decree supporting the introduction of its new reference pricing system from March 2007. The measure clarifies that price revisions will take place once per year,... 2006-11-22

According to Genoma Espana - a government-industry forum promoting Spain's biotechnology industry - venture capitalists remain wary of investing in local companies that are active... 2006-11-16

As the Spanish government is set to introduce its new cost-cutting reforms to the country's pharmaceutical sector, Emilio Moraleda, the local chief of Pfizer, has lamented the outlook... 2006-10-31

Spanish health officials are campaigning against the inappropriate use of antibiotics, amid signs that up to 30% of anti-infectives are routinely dispensed without a prescription,... 2006-10-23

Wanbury - an Indian pharmaceuticals and active ingredients manufacturer that claims to be the world's largest producer of the diabetes agent metformin - is to acquire an unidentified... 2006-10-13

Innovator drug companies operating in Spain have launched an attack on provisions regarding generic substitution in the new Medicines Law. Article 85 encourages pharmacists to substitute... 2006-10-03

The UK's GlaxoSmithKline (GSK) has won a landmark test case upholding the firm's right to restrict supplies to the Spanish market, in an attempt to halt undercutting in other markets... 2006-09-28

Spanish government officials have confirmed that the country's universal reference pricing system will come into effect on March 1, 2007. Government sources believe the newly expanded... 2006-09-13

Spain's leading health policy fund, the Instituto Carlos III, is to make research into nanomedicines a new priority. The plans reflect not only heavy investment by the European Union... 2006-09-07